Compass Therapeutics, Inc. (CMPX): A Bull Case Theory [Yahoo! Finance]
Compass Therapeutics, Inc. (CMPX)
Company Research
Source: Yahoo! Finance
Compass Therapeutics, Inc.'s share was trading at $5.70 as of January 16th. Compass Therapeutics (CMPX) is a clinical-stage oncology company with a focused pipeline targeting large, underserved cancer markets, and its current valuation appears disconnected from the scale of its opportunity. With a share price around $6 and a market capitalization of approximately $1.2 billion, the company holds a strong cash position of $209 million against a historically manageable annual cash burn of $30–50 million, providing runway through multiple critical data readouts. Ownership quality is a key differentiator, with roughly 65% institutional ownership led by specialist healthcare investors such as Tang Capital, OrbiMed, Suvretta, Vivo, BVF, and Patient Square, alongside 10% insider ownership and a long-tenured board that signals strategic continuity. The core value driver is CTX-009 (tovecimig), with a Phase 3 program in biliary tract cancer targeting an estimated $1.5 billion peak sales opp
Show less
Read more
Impact Snapshot
Event Time:
CMPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMPX alerts
High impacting Compass Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CMPX
News
- Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CMPX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StMarketBeat
- Assessing Compass Therapeutics (CMPX) Valuation After Strong 1 Year Share Price Performance [Yahoo! Finance]Yahoo! Finance
- Is Compass Therapeutics (CMPX) Quietly Rewriting Its Oncology Strategy With New Commercial and Medical Chiefs? [Yahoo! Finance]Yahoo! Finance
- Compass Therapeutics Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Compass Therapeutics (NASDAQ:CMPX) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
CMPX
Earnings
- 8/11/25 - Miss
CMPX
Sec Filings
- 1/12/26 - Form 4
- 1/8/26 - Form EFFECT
- 1/6/26 - Form 8-K
- CMPX's page on the SEC website